Portfolio

We say no to far more than we say yes. These are the medical device companies we have backed.

Our portfolio is concentrated by design. We have raised nearly $50M to invest in the companies below.

Realized Outcomes

Two acquisitions to date. Auris Health to Johnson & Johnson (2019) and Uromedica to Coloplast (2026), each from the platform's earliest investment vehicles, Turambar and Felagund.

Each investment is organized as its own dedicated, single-asset vehicle. Vehicles are managed by Telperion Manager LLC or by Athelas Manager LLC, as indicated on each investment. All vehicles are organized as Delaware limited liability companies and offered on a private placement basis to accredited investors only. This site is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any offer or solicitation will be made only through confidential offering materials and only to persons who, among other requirements, are accredited investors. Any figures shown (including amounts raised) are approximate and presented as of the dates indicated; they are subject to change without notice. Telperion Manager LLC and Athelas Manager LLC are each exempt reporting advisers and are not registered as investment advisers with the U.S. Securities and Exchange Commission. Past investments are not indicative of future results.

Telperion PartnersTelperion Partners

Telperion Partners LLC · Delaware

This site is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. Any offering is made only by confidential offering documents to eligible investors (including accredited investors) and is subject to final terms and conditions.

© 2026 Telperion Partners LLC

All Rights Reserved · Accredited Investors Only